Promising results from first gene therapy clinical trial for Parkinson’s disease reported
In what could be a breakthrough in the treatment of neurological disease, a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has completed the first-ever phase 1 clinical trial using gene therapy to battle Parkinson’s disease.
The study of 11 men and one woman with the progressive neurodegenerative illness found that the procedure—in which surgeons inject a harmless gene-bearing virus into the brain—was both safe and resulted in improved motor function for Parkinson’s patients over the course of one year. The findings are published in the June 23 issue of The Lancet.
Page 1 of 1 pages
